vs

Side-by-side financial comparison of Emerald Holding, Inc. (EEX) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $132.7M, roughly 1.6× Emerald Holding, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -22.8%, a 25.4% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 24.3%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $11.7M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -0.3%).

TVS Emerald Haven Realty Limited is an Indian real estate development company headquartered in Chennai, Tamil Nadu. A subsidiary of TVS Holdings, it specializes in sustainable residential communities and urban development projects.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

EEX vs IRTC — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.6× larger
IRTC
$208.9M
$132.7M
EEX
Growing faster (revenue YoY)
IRTC
IRTC
+2.9% gap
IRTC
27.1%
24.3%
EEX
Higher net margin
IRTC
IRTC
25.4% more per $
IRTC
2.7%
-22.8%
EEX
More free cash flow
IRTC
IRTC
$2.8M more FCF
IRTC
$14.5M
$11.7M
EEX
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
-0.3%
EEX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EEX
EEX
IRTC
IRTC
Revenue
$132.7M
$208.9M
Net Profit
$-30.2M
$5.6M
Gross Margin
70.9%
Operating Margin
-11.8%
1.1%
Net Margin
-22.8%
2.7%
Revenue YoY
24.3%
27.1%
Net Profit YoY
-692.2%
518.5%
EPS (diluted)
$-0.15
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EEX
EEX
IRTC
IRTC
Q4 25
$132.7M
$208.9M
Q3 25
$77.5M
$192.9M
Q2 25
$105.5M
$186.7M
Q1 25
$147.7M
$158.7M
Q4 24
$106.8M
$164.3M
Q3 24
$72.6M
$147.5M
Q2 24
$86.0M
$148.0M
Q1 24
$133.4M
$131.9M
Net Profit
EEX
EEX
IRTC
IRTC
Q4 25
$-30.2M
$5.6M
Q3 25
$-14.4M
$-5.2M
Q2 25
$-1.4M
$-14.2M
Q1 25
$15.3M
$-30.7M
Q4 24
$5.1M
$-1.3M
Q3 24
$-11.1M
$-46.2M
Q2 24
$-2.8M
$-20.1M
Q1 24
$11.0M
$-45.7M
Gross Margin
EEX
EEX
IRTC
IRTC
Q4 25
70.9%
Q3 25
71.1%
Q2 25
71.2%
Q1 25
68.8%
Q4 24
70.0%
Q3 24
68.8%
Q2 24
69.9%
Q1 24
66.3%
Operating Margin
EEX
EEX
IRTC
IRTC
Q4 25
-11.8%
1.1%
Q3 25
-10.1%
-4.4%
Q2 25
9.7%
-10.0%
Q1 25
24.2%
-20.5%
Q4 24
19.5%
-2.5%
Q3 24
-6.5%
-34.1%
Q2 24
7.4%
-15.5%
Q1 24
18.2%
-28.9%
Net Margin
EEX
EEX
IRTC
IRTC
Q4 25
-22.8%
2.7%
Q3 25
-18.6%
-2.7%
Q2 25
-1.3%
-7.6%
Q1 25
10.4%
-19.3%
Q4 24
4.8%
-0.8%
Q3 24
-15.3%
-31.3%
Q2 24
-3.3%
-13.6%
Q1 24
8.2%
-34.6%
EPS (diluted)
EEX
EEX
IRTC
IRTC
Q4 25
$-0.15
$0.18
Q3 25
$-0.07
$-0.16
Q2 25
$-0.01
$-0.44
Q1 25
$0.08
$-0.97
Q4 24
$0.01
$-0.03
Q3 24
$-0.05
$-1.48
Q2 24
$-0.03
$-0.65
Q1 24
$0.00
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EEX
EEX
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$100.9M
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$338.8M
$152.7M
Total Assets
$1.2B
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EEX
EEX
IRTC
IRTC
Q4 25
$100.9M
$583.8M
Q3 25
$95.4M
$565.2M
Q2 25
$156.4M
$545.5M
Q1 25
$276.8M
$520.6M
Q4 24
$194.8M
$535.6M
Q3 24
$188.9M
$522.0M
Q2 24
$193.2M
$561.5M
Q1 24
$186.8M
$569.1M
Stockholders' Equity
EEX
EEX
IRTC
IRTC
Q4 25
$338.8M
$152.7M
Q3 25
$369.5M
$121.9M
Q2 25
$389.4M
$103.7M
Q1 25
$392.1M
$86.7M
Q4 24
$385.9M
$90.9M
Q3 24
$391.1M
$71.8M
Q2 24
$407.6M
$99.2M
Q1 24
$-90.7M
$90.3M
Total Assets
EEX
EEX
IRTC
IRTC
Q4 25
$1.2B
$1.0B
Q3 25
$1.2B
$995.2M
Q2 25
$1.2B
$964.0M
Q1 25
$1.2B
$926.1M
Q4 24
$1.0B
$931.4M
Q3 24
$1.1B
$909.7M
Q2 24
$1.1B
$919.2M
Q1 24
$1.1B
$909.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EEX
EEX
IRTC
IRTC
Operating Cash FlowLast quarter
$12.3M
$26.2M
Free Cash FlowOCF − Capex
$11.7M
$14.5M
FCF MarginFCF / Revenue
8.8%
6.9%
Capex IntensityCapex / Revenue
0.5%
5.6%
Cash ConversionOCF / Net Profit
4.70×
TTM Free Cash FlowTrailing 4 quarters
$41.4M
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EEX
EEX
IRTC
IRTC
Q4 25
$12.3M
$26.2M
Q3 25
$1.8M
$34.9M
Q2 25
$15.9M
$27.7M
Q1 25
$12.6M
$-7.9M
Q4 24
$20.6M
$19.2M
Q3 24
$9.1M
$24.3M
Q2 24
$9.8M
$11.8M
Q1 24
$7.3M
$-52.0M
Free Cash Flow
EEX
EEX
IRTC
IRTC
Q4 25
$11.7M
$14.5M
Q3 25
$1.5M
$20.1M
Q2 25
$15.8M
$17.3M
Q1 25
$12.4M
$-17.3M
Q4 24
$19.9M
$12.4M
Q3 24
$9.0M
$15.5M
Q2 24
$9.6M
$3.4M
Q1 24
$7.0M
$-61.8M
FCF Margin
EEX
EEX
IRTC
IRTC
Q4 25
8.8%
6.9%
Q3 25
1.9%
10.4%
Q2 25
15.0%
9.3%
Q1 25
8.4%
-10.9%
Q4 24
18.6%
7.5%
Q3 24
12.4%
10.5%
Q2 24
11.2%
2.3%
Q1 24
5.2%
-46.8%
Capex Intensity
EEX
EEX
IRTC
IRTC
Q4 25
0.5%
5.6%
Q3 25
0.4%
7.7%
Q2 25
0.1%
5.6%
Q1 25
0.1%
5.9%
Q4 24
0.7%
4.2%
Q3 24
0.1%
6.0%
Q2 24
0.2%
5.7%
Q1 24
0.2%
7.4%
Cash Conversion
EEX
EEX
IRTC
IRTC
Q4 25
4.70×
Q3 25
Q2 25
Q1 25
0.82×
Q4 24
4.04×
Q3 24
Q2 24
Q1 24
0.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EEX
EEX

Connections Segment$121.9M92%
Commerce Segment$5.5M4%
Content$5.3M4%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons